Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to evaluate whether a scalp moisturizer containing celastrol and Cichorium intybus root extract can improve scalp condition in adults aged 19 years or older who require scalp moisturization due to dryness, scaling, erythema, or dandruff. The main questions it aims to answer are:
Does once-daily application of the study moisturizer improve scalp condition from baseline to week 4, as assessed by SPI-AI (Scalp Photographic Index-Artificial Intelligence)?
Does the moisturizer improve scalp biophysical parameters (erythema index, stratum corneum hydration, and transepidermal water loss) and patient-reported symptom severity over the 4-week treatment period?
Participants will:
Apply the study moisturizer once daily at bedtime to dry scalp for 4 weeks and rinse it off the following morning using their usual shampoo.
Attend study visits at baseline (week 0), week 2, and week 4 for scalp imaging, biophysical measurements, symptom questionnaires, adherence assessment, and safety monitoring.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Moisturizer | Active Comparator | participants applies the moisturizer once daily to the entire scalp at bedtime |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ducray Kertyol P.S.O. Concentrate Cream, Ducray Laboratory, France | Other | participants applied the moisturizer once daily to the entire scalp at bedtime |
|
| Measure | Description | Time Frame |
|---|---|---|
| SPI-AI | Scalp Photographic Index with artificial intelligence | 4week |
| Measure | Description | Time Frame |
|---|---|---|
| SPI-AI | Scalp Photographic Index with artificial intelligence | 2week |
| Biophysical parameter | erythema index (arbitrary unit) | 2week |
Not provided
Inclusion Criteria
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si | Kyeonggi | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Biophysical parameter | erythema index (arbitrary unit) | 4week |
| Biophysical parameter | corneometer (arbitrary unit) | 2 week |
| Biophysical parameter | corneometer (arbitrary unit) | 4 week |
| Biophysical parameter | transepidermal water loss (g/m2/h) | 2 week |
| Biophysical parameter | transepidermal water loss (g/m2/h) | 4 week |
| Patient-reported outcome | visual analog scale (0-10) : higher is worse | 2 week |
| Patient-reported outcome | visual analog scale (0-10) : higher is worse | 4 week |
| ID | Term |
|---|---|
| D063807 | Dandruff |
| ID | Term |
|---|---|
| D003872 | Dermatitis |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012536 | Scalp Dermatoses |
Not provided
Not provided